Studies have shown that joint mobility is more severe in RA patients with anemia (32), interleukin-6 (IL-6), CRP, and CCP levels are significantly elevated in anemic RA patients compared to non-anemic RA patients, indicating high disease activity (31). Here, IL6 is linked to rheumatoid arthritis.